PF-04554878 5mg 5mg | Purity Not Available
Adooq Bioscience
PF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRoxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageRoxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier Page